Stevanovic S - Search Results

1

Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR.

Sun Y, Song M, Jäger E, Schwer C, Stevanovic S, Flindt S, Karbach J, Nguyen XD, Schadendorf D, Cichutek K. Sun Y, et al. Among authors: stevanovic s. Clin Cancer Res. 2008 Jul 1;14(13):4306-15. doi: 10.1158/1078-0432.CCR-07-4849. Clin Cancer Res. 2008. PMID: 18594014

2

The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes.

Sun Y, Stevanovic S, Song M, Schwantes A, Kirkpatrick CJ, Schadendorf D, Cichutek K. Sun Y, et al. Among authors: stevanovic s. Blood. 2006 Feb 15;107(4):1476-83. doi: 10.1182/blood-2005-05-1912. Epub 2005 Oct 18. Blood. 2006. PMID: 16234362 Free article.

3

Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.

Sun Y, Sijts AJ, Song M, Janek K, Nussbaum AK, Kral S, Schirle M, Stevanovic S, Paschen A, Schild H, Kloetzel PM, Schadendorf D. Sun Y, et al. Among authors: stevanovic s. Cancer Res. 2002 May 15;62(10):2875-82. Cancer Res. 2002. PMID: 12019167

4

Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2.

Paschen A, Jing W, Drexler I, Klemm M, Song M, Müller-Berghaus J, Nguyen XD, Osen W, Stevanovic S, Sutter G, Schadendorf D. Paschen A, et al. Among authors: stevanovic s. Int J Cancer. 2005 Oct 10;116(6):944-8. doi: 10.1002/ijc.21132. Int J Cancer. 2005. PMID: 15856458 Free article.

5

Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen.

Sun Y, Song M, Stevanović S, Jankowiak C, Paschen A, Rammensee HG, Schadendorf D. Sun Y, et al. Among authors: stevanovic s. Int J Cancer. 2000 Aug 1;87(3):399-404. doi: 10.1002/1097-0215(20000801)87:3<399::aid-ijc14>3.0.co;2-9. Int J Cancer. 2000. PMID: 10897046 Free article.

6

Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.

Scheibenbogen C, Sun Y, Keilholz U, Song M, Stevanovic S, Asemissen AM, Nagorsen D, Thiel E, Rammensee HG, Schadendorf D. Scheibenbogen C, et al. Among authors: stevanovic s. Int J Cancer. 2002 Mar 20;98(3):409-14. doi: 10.1002/ijc.10205. Int J Cancer. 2002. PMID: 11920592 Free article.

7

A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays.

Weinzierl AO, Maurer D, Altenberend F, Schneiderhan-Marra N, Klingel K, Schoor O, Wernet D, Joos T, Rammensee HG, Stevanović S. Weinzierl AO, et al. Among authors: stevanovic s. Cancer Res. 2008 Apr 1;68(7):2447-54. doi: 10.1158/0008-5472.CAN-07-2540. Cancer Res. 2008. PMID: 18381453

8

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.

Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, Lübke M, Bauer J, Rieth J, Wacker M, Peter A, Hörber S, Traenkle B, Kaiser PD, Rothbauer U, Becker M, Junker D, Krause G, Strengert M, Schneiderhan-Marra N, Templin MF, Joos TO, Kowalewski DJ, Stos-Zweifel V, Fehr M, Rabsteyn A, Mirakaj V, Karbach J, Jäger E, Graf M, Gruber LC, Rachfalski D, Preuß B, Hagelstein I, Märklin M, Bakchoul T, Gouttefangeas C, Kohlbacher O, Klein R, Stevanović S, Rammensee HG, Walz JS. Nelde A, et al. Among authors: stevanovic s. Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30. Nat Immunol. 2021. PMID: 32999467

9

Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen.

Boss CN, Grünebach F, Brauer K, Häntschel M, Mirakaj V, Weinschenk T, Stevanovic S, Rammensee HG, Brossart P. Boss CN, et al. Among authors: stevanovic s. Clin Cancer Res. 2007 Jun 1;13(11):3347-55. doi: 10.1158/1078-0432.CCR-06-2156. Clin Cancer Res. 2007. PMID: 17545542

10

Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.

Dengjel J, Nastke MD, Gouttefangeas C, Gitsioudis G, Schoor O, Altenberend F, Müller M, Krämer B, Missiou A, Sauter M, Hennenlotter J, Wernet D, Stenzl A, Rammensee HG, Klingel K, Stevanović S. Dengjel J, et al. Among authors: stevanovic s. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4163-70. doi: 10.1158/1078-0432.CCR-05-2470. Clin Cancer Res. 2006. PMID: 16857787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

450 results

Search Page